Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
• Marvell Technology Group Ltd. (NASDAQ: ( MRVL - Snapshot Report ) reported first quarter fiscal 2012 adjusted earnings per share of 24 cents, 2 cents shy of the Zacks Consensus Estimate of 26 cents. Despite the miss, shares increased 8.86% in after-market trade on encouraging second quarter guidance
• Graham Corp. (AMEX: ( GHM - Snapshot Report ) reported fourth quarter EPS of 27 cents, ahead of the Zacks Consensus Estimate of 19 cents per share
• Google Inc. (NASDAQ: ( GOOG - Analyst Report ) was sued by eBay Inc.'s (NASDAQ: ( EBAY - Analyst Report ) PayPal over allegations of stealing mobile payment technology trade secrets
• Morgan Stanley (NYSE: ( MS - Analyst Report ) downgraded AFLAC Inc. (NYSE: ( AFL - Analyst Report ) to equal weight
• It was reported that MedcoHealth Solutions Inc. (NYSE: ( ) will lose the Federal Employee Program contract to CVS Caremark Corporation (NYSE: ( CVS - Analyst Report ) , effective January 2012
• The Goldman Sachs Group, Inc. (NYSE: ( GS - Analyst Report ) upgraded its rating on Nasdaq OMX Group Inc. (NASDAQ: ( NDAQ - Analyst Report ) to buy after the latter failed to successfully bid for NYSE Euronext, Inc. (NYSE: ( NYX - Analyst Report )
• Comments from FBR Capital Markets Corporation (NASDAQ: ( ) stating that growing demand for smartphones will benefit Broadcom Corp. (NASDAQ:BRCM) lifted BRCM's share price by 5.4%
• Deutsche Bank AG (NYSE:DB) downgraded Weyerhaeuser Co. (NYSE:WY) to Sell from Hold
• Wells Fargo & Company (NYSE:WFC) upgraded Entergy Corporation (NYSE:ETR) to Outperform from Market Perform
Read the full Snapshot Report on MRVL
Read the full Snapshot Report on GHM
Read the full Analyst Report on GOOG
Read the full Analyst Report on EBAY
Read the full Analyst Report on MS
Read the full Analyst Report on AFL
Read the full Analyst Report on CVS
Read the full Analyst Report on GS
Read the full Analyst Report on NDAQ
Read the full Analyst Report on NYX